Aetna to sell its Medicare Part D drug plan
In the hopes of winning regulatory approval from the Trump administration, Aetna has agreed to sell its Medicare Part D
Read MoreIn the hopes of winning regulatory approval from the Trump administration, Aetna has agreed to sell its Medicare Part D
Read More(By Alia Paavola for Becker’s Hospital Review) Gilead Sciences will offer a cheaper version of its blockbuster hepatitis C drugs,
Read More(By Morgan Haefner for Becker’s Hospital Review) Blue Cross Blue Shield of Michigan will pay more than 520,000 policyholders for
Read More(By Morgan Haefner for Becker’s Hospital Review) Americans with health insurance coverage through their employer — the largest insured population
Read More(By Ed Silverman for STAT) As prices for diabetes treatments continue to roil consumers, a new study suggests that manufacturers
Read More(By Jackie Fortier for NPR) Air ambulance rides can be lifesavers. But how much should they cost? In the ongoing,
Read More(By Jordan Rau for Kaiser Health News) On orders from Congress, Medicare is easing up on its annual readmission penalties
Read MoreAccording to a recent survey by the National Business Group on Health more than 9 out of 10 employers expect
Read MoreMedicare’s open enrollment period is nearing – it runs from October 15 through December 7 – giving you a golden
Read MoreHealth care costs the average retiree $499 a month when you consider the various deductibles, co-pays, and premiums associated with
Read More